Streamline Health Solutions (STRM) AI Stock Analysis

• Market Cap: $21.46M
• Dividend Yield: N/A
• Average Volume (3M): 123.00K
• Price to Earnings (P/E): ―
• Beta (1Y): 2.21
• Revenue Growth: -20.78%
• EPS Growth: 49.22%
• Country: US
• Employees: 70
• Sector: Healthcare
• Sector Strength: 41
• Industry: Medical - Healthcare Information Services
• EPS (TTM): -0.42
• Shares Outstanding: 4,325,290
• 10 Day Avg. Volume: 354,758
• 30 Day Avg. Volume: 122,997
• PEG Ratio: -0.02
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -3.33
• Enterprise Value/Market Cap: -101.22
• Enterprise Value/Revenue: -26.14
• Enterprise Value/Gross Profit: -233.62
• Enterprise Value/Ebitda: 51.48
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 59 Neutral
• Price Target: $5.50 ▲(5.97%Upside)

Streamline Health Solutions' overall stock score is heavily influenced by its financial struggles, which significantly lower its score. However, strong technical momentum and a promising merger announcement with MDaudit provide notable positive offsets. The negative valuation metrics and high financial risk temper enthusiasm, but the corporate event suggests potential future improvements.

Streamline Health Solutions Business Overview & Revenue Model

Company Description

Streamline Health Solutions, Inc. offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. It provides computer software-based solutions, professional consulting, and auditing and coding services, which capture, aggregate, and translate structured and unstructured data to deliver predictive insights. The company also offers coding and clinical documentation improvement (CDI) solutions, which include an integrated cloud-based software suite, CDI, and abstracting and physician query; and eValuator, a coding analysis platform, as well as software services. In addition, it provides financial management solutions, including accounts receivable management, denials management, claims processing, spend management, and audit management; patient care solutions; Cerner Command Language (CCL) reporting; and custom integration services for CDI/abstracting, training, and audit services. The company sells its solutions and services through direct sales force and reseller partnerships. Streamline Health Solutions, Inc. was incorporated in 1989 and is based in Alpharetta, Georgia.

How the Company Makes Money

Streamline Health Solutions generates revenue through the sale and subscription of its software solutions, which are primarily targeted at healthcare providers looking to enhance their revenue cycle processes. The company charges licensing fees for its software products and also earns recurring revenue through subscription-based services, which may include software updates, technical support, and additional features. Furthermore, Streamline Health Solutions engages in professional services for implementation, training, and consulting, which constitute another revenue stream. Partnerships with other healthcare technology firms and entities may also play a role in expanding their market reach and enhancing their product offerings.

Streamline Health Solutions Financial Statement Overview

Summary

Streamline Health Solutions shows a worrying financial profile characterized by significant operational losses, high leverage, and negative cash flow. While revenue growth in the TTM period is a positive sign, the company is struggling with profitability and cash conversion issues. High debt levels further exacerbate potential risks, demanding urgent strategic adjustments to improve financial health.

Income Statement

The income statement shows a concerning trend with persistent net losses and negative EBIT and EBITDA margins. The company's TTM revenue has grown significantly, but this is overshadowed by substantial negative EBIT, indicating operational inefficiencies. Gross profit margin is very high, suggesting potential pricing power or cost control at the gross level, yet this does not translate into profitability due to high operating expenses.

Balance Sheet

The balance sheet reveals high leverage with a significant debt-to-equity ratio, posing a risk in terms of financial stability. Despite positive stockholders' equity, the equity ratio is relatively low, indicating potential solvency concerns. The company's liabilities significantly outweigh its assets, which is a critical risk factor.

Cash Flow

Cash flow analysis indicates severe issues with sustaining positive free cash flow, as operating cash flow is significantly negative. The free cash flow to net income ratio is unfavorable, reflecting difficulties in converting earnings to cash. The company also faces challenges in managing capital expenditures effectively.

Breakdown
TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement		Total Revenue
18.59M	0.00	22.60M	24.89M	17.38M	11.35M
	Gross Profit
9.30M	0.00	11.54M	11.49M	8.80M	5.66M
	EBIT
-6.78M	0.00	-19.65M	-10.83M	-10.77M	-5.84M
	EBITDA
-2.97M	0.00	-12.82M	-6.25M	-2.93M	-4.80M
	Net Income Common Stockholders
-9.39M	0.00	-18.70M	-11.38M	-6.92M	-4.80M
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
754.00K	0.00	3.19M	6.60M	9.88M	2.41M
	Total Assets
35.97M	0.00	41.73M	61.52M	61.81M	25.98M
	Total Debt
12.26M	12.12B	10.57M	9.75M	10.14M	2.72M
	Net Debt
11.51M	12.12B	7.38M	3.15M	256.00K	312.00K
	Total Liabilities
22.05M	23.30B	22.92M	26.01M	27.77M	8.49M
	Stockholders Equity
13.91M	12.28B	18.81M	35.51M	34.04M	17.49M
Cash Flow		Free Cash Flow
-3.37M	0.00	-3.84M	-9.08M	-5.00M	-7.58M
	Operating Cash Flow
-2.69M	0.00	-2.21M	-7.14M	-3.50M	-5.76M
	Investing Cash Flow
-679.00K	0.00	-1.62M	-1.94M	-13.17M	9.46M
	Financing Cash Flow
1.57M	0.00	428.00K	5.79M	24.15M	-2.94M

Streamline Health Solutions Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 5.19
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Negative
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For STRM, the sentiment is Positive. The current price of 5.19 is above the 20-day moving average (MA) of 2.97, above the 50-day MA of 2.78, and above the 200-day MA of 3.52, indicating a bullish trend. The MACD of 0.53 indicates Negative momentum. The RSI at 84.68 is Negative, neither overbought nor oversold. The STOCH value of 99.36 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for STRM.

Streamline Health Solutions Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
STRM	59 Neutral	$21.46M	―	-65.35%	―	-20.78%	49.22%
Sector *	53 Neutral	$5.23B	3.23	-44.27%	2.82%	16.82%	0.11%
PRPH	47 Neutral	$15.52M	―	-58.71%	―	-79.66%	-141.87%
BCDA	39 Underperform	$11.70M	―	-737.89%	―	-99.36%	63.06%
CTXR	38 Underperform	$7.92M	―	-60.06%	―	―	8.99%
LPTX	31 Underperform	$14.86M	―	-202.81%	―	―	64.01%
MOVE	23 Underperform	$4.48M	―	-439.23%	―	―	56.73%

Streamline Health Solutions Corporate Events

Streamline Health Solutions Announces Merger with MDaudit

On May 29, 2025, Streamline Health Solutions entered into a merger agreement with MDaudit, under which MDaudit will acquire all outstanding shares of Streamline for $5.34 per share in cash, representing a 138% premium over Streamline’s closing price on May 28, 2025. This merger aims to combine Streamline’s pre-bill integrity solutions with MDaudit’s billing compliance and revenue integrity platform, enhancing the ability to unify data silos and drive coordinated actions across the revenue cycle continuum, ultimately improving financial stability for healthcare organizations.

The most recent analyst rating on (STRM) stock is a Buy with a $22.50 price target. To see the full list of analyst forecasts on Streamline Health Solutions stock, see the STRM Stock Forecast page.